Mastering Palliative Care Symptom Management for MRCP PACES
Why Palliative Care is High-Yield in MRCP PACES
Palliative care scenarios appear frequently in MRCP PACES, particularly in Stations 2 and 5, where candidates must demonstrate not only clinical knowledge but also the ability to manage complex symptoms in patients with life-limiting illnesses. Examiners assess whether you can deliver holistic, patient-centred care while applying evidence-based guidelines. A common pitfall is focusing solely on communication skills while neglecting the pharmacological and clinical management of distressing symptoms. This guide bridges that gap, equipping you with the knowledge to confidently manage palliative symptoms under exam pressure.
Core Symptom Domains You Must Master
1. Pain Management in Palliative Care
Pain is the most commonly encountered symptom in palliative care PACES scenarios. You must be fluent in the WHO analgesic ladder and understand how to escalate treatment appropriately.
Key Principles:
Assess pain using a structured approach (site, character, severity, exacerbating/relieving factors)
Distinguish between nociceptive (somatic/visceral) and neuropathic pain, as this guides therapy
Prescribe according to the WHO ladder:
Step 1: Non-opioid (e.g., paracetamol, NSAIDs with PPI cover)
Step 2: Weak opioid (e.g., codeine, tramadol)
Step 3: Strong opioid (e.g., morphine, oxycodone)
Opioid Conversion Essentials:
| Drug | Oral Dose (mg) | Subcutaneous Dose (mg) |
|---|---|---|
| Morphine | 10 | 5 |
| Oxycodone | 6.6 | 3.3 |
| Diamorphine | — | 3 |
Exam Tip: Always prescribe a breakthrough dose equal to 1/6th to 1/10th of the total 24-hour opioid dose, given every 1–2 hours PRN.
Neuropathic Pain:
If pain has a neuropathic component, add adjuvants:
Gabapentin (300mg starting dose, titrate)
Amitriptyline (10–25mg nocte)
Consider nerve blocks or radiotherapy for specific indications
2. Nausea and Vomiting
This is a frequently tested area. The key is to identify the underlying cause and select an antiemetic that targets the relevant receptor pathway.
Mechanism-Based Antiemetic Selection:
| Cause | Receptor Pathway | First-Line Antiemetic |
|---|---|---|
| Gastric stasis / bowel obstruction | Histamine H1 / ACh M1 | Cyclizine 50mg PO/SC tds |
| Chemical/metabolic (opioid-induced, renal failure) | Dopamine D2 | Haloperidol 0.5–1.5mg SC od-bd |
| Raised intracranial pressure | Histamine H1 | Cyclizine 50mg tds |
| Vestibular | Histamine H1 / ACh M1 | Cyclizine or prochlorperazine |
| Anxiety-related | 5-HT | Lorazepam (short-term) |
High-Yield Point: In bowel obstruction, combine cyclizine with an antisecretory agent (octreotide 200–600mcg/24h SC or hyoscine butylbromide 60–120mg/24h SC) to reduce colic and vomiting.
3. Breathlessness (Dyspnoea) in Advanced Disease
Breathlessness is devastating for patients and frequently appears in PACES consultations. Your management must address both the reversible causes and the symptomatic relief.
Management Framework:
Treat reversible causes:
Pleural effusion → aspiration/drainage
Pulmonary oedema → diuretics
Anaemia → transfusion (if appropriate in goals of care)
Infection → antibiotics (if aligned with patient wishes)
Bronchospasm → bronchodilators
Symptomatic management:
Low-dose oral morphine (2.5mg every 4 hours) — reduces ventilatory drive and the distressing sensation of breathlessness without significant respiratory depression when used appropriately
Oxygen — only if hypoxic (SpO₂ < 90%); not beneficial for non-hypoxic dyspnoea
Benzodiazepines (lorazepam 0.5–1mg PRN) — for anxiety-associated dyspnoea
Fans and upright positioning — simple non-pharmacological measures
Breathlessness clinics and CBT-based strategies for ongoing support
Exam Trap: Do NOT say 'oxygen for everyone with breathlessness.' Examiners will challenge this. Only prescribe oxygen for the hypoxic patient.
4. Terminal Agitation and Restlessness
This is a critical area where candidates often falter. Terminal agitation requires prompt recognition and management, as it causes immense distress to patients and families.
Causes of Terminal Agitation:
Urinary retention
Constipation / faecal impaction
Pain
Delirium (metabolic, infective, drug-induced)
Fear and anxiety
Spiritual distress
Management:
Address reversible causes first. Then:
Haloperidol 0.5–2mg SC every 2–4 hours (for delirium)
Midazolam 10–20mg/24h SC infusion (for severe agitation/anxiety)
Levomepromazine 12.5–25mg SC od-bd (for resistant cases)
Critical PACES Point: Always distinguish terminal agitation from terminal restlessness due to pain. If a patient is agitated and on opioids, consider whether they are in uncontrolled pain rather than simply sedating them further.
5. Respiratory Tract Secretions ('Death Rattle')
This occurs in the last hours to days of life and is distressing for families. Understanding this is essential for PACES.
Management:
Hyoscine hydrobromide 400mcg SC every 2–4 hours (antisecretory)
Hyoscine butylbromide 20mg SC every 4–6 hours (if sedation undesirable)
Glycopyrronium 200mcg SC every 6–8 hours
Position the patient semi-prone and explain to the family that the patient is likely unconscious and not distressed by the secretions
Key Communication Point: Reassure the family that noisy breathing does not mean the patient is suffering. This is one of the most important counselling points in terminal care.
Common PACES Scenarios in Palliative Care
Scenario 1: Metastatic Cancer with Uncontrolled Pain
A 68-year-old woman with metastatic breast cancer is on 30mg oral morphine twice daily but still has breakthrough pain 3–4 times per day. She rates her pain as 7/10.
What you must address:
Total daily morphine dose = 60mg
Breakthrough dose = 60 ÷ 6 = 10mg oral morphine PRN
Assess pain type — is it bone pain? Consider adding an NSAID or bisphosphonate
Escalate — if breakthrough pain is frequent, increase the regular dose by 30–50%
Consider fentanyl patches or PCA if oral route is problematic
Scenario 2: Bowel Obstruction in Advanced Ovarian Cancer
A 72-year-old woman with advanced ovarian cancer presents with colicky abdominal pain and vomiting.
Management plan:
Cyclizine 50mg SC tds (antiemetic for obstruction)
Hyoscine butylbromide 60–120mg/24h SC infusion (for colic)
Octreotide 200–600mcg/24h SC infusion (reduces secretions)
Diamorphine SC (if opioid-naïve) or continue current opioid converted to SC equivalent
Consider dexamethasone 6–16mg SC od (may reduce peritumoural oedema)
NG tube for decompression if vomiting persists
Discuss surgical options if appropriate (single-level obstruction with good performance status)
Scenario 3: Syringe Driver Prescription
Examiners may ask you to convert a patient's oral medications to a continuous subcutaneous infusion (syringe driver) when the oral route is lost.
Conversion Example:
| Drug | Oral Dose | SC Equivalent (24h) |
|---|---|---|
| Morphine | 30mg/24h | 15mg/24h |
| Midazolam | 10mg/24h PO | 10mg/24h SC |
| Cyclizine | 150mg/24h PO | 150mg/24h SC |
Compatibility Check: Remember that cyclizine is incompatible with many drugs in a syringe driver (including diamorphine). Check a palliative care formulary or use a dedicated compatibility resource.
The 'Liverpool Care Pathway' Controversy and Modern Individualised Care Plans
You should be aware that the Liverpool Care Pathway (LCP) was phased out in the UK in 2014 following concerns about poor implementation. Modern palliative care emphasises individualised care plans for the dying patient.
Key elements of a good care plan for the dying patient:
Recognition of dying — documented with rationale
Communication with patient (if possible) and family
Symptom assessment — regular re-assessment every 4 hours
Anticipatory prescribing ('just in case' box)
Spiritual and psychological support
Regular review by the medical team
Examiners' Favourite: 'What would you prescribe in anticipation of common symptoms at the end of life?' — Know the standard anticipatory ('just in case') medications.
Standard Anticipatory Prescribing:
| Symptom | Drug | Route & Dose |
|---|---|---|
| Pain | Diamorphine or Morphine | SC 2.5–5mg PRN |
| Nausea/Vomiting | Haloperidol or Levomepromazine | SC 0.5–1.25mg PRN |
| Agitation | Midazolam | SC 2.5–5mg PRN |
| Secretions | Hyoscine hydrobromide | SC 400mcg PRN |
Structuring Your PACES Palliative Care Consultation
When presenting to the examiner, follow this structure:
1. Clinical Summary (30 seconds)
'This is a 70-year-old man with metastatic lung cancer presenting with worsening breathlessness and pain, consistent with disease progression.'
2. Key Problems Identified (30 seconds)
'His main problems are:
Uncontrolled pain (likely mixed nociceptive and neuropathic)
Breathlessness with hypoxia
Psychological distress
Advance care planning needs'
3. Management Plan (60–90 seconds)
'I would:
Optimise analgesia by increasing his regular morphine and prescribing appropriate breakthrough doses
Add a neuropathic agent for the neuropathic component
Commence low-dose morphine for breathlessness and consider oxygen given his hypoxia
Refer to the specialist palliative care team
Discuss advance care planning, including resuscitation status and preferred place of death
Offer psychological and spiritual support'
4. Ongoing Care and Family Communication
'I would ensure regular reassessment, provide a named key worker, and communicate openly with the family about the prognosis and goals of care.'
Common Mistakes That Cost Candidates Marks
Not knowing opioid conversion ratios — examiners will test this directly
Prescribing oxygen for all breathlessness — only for hypoxic patients
Failing to address psychological and spiritual needs — palliative care is holistic
Not knowing the standard 'just in case' medications — this is fundamental knowledge
Over-sedating without reviewing — always reassess the cause of agitation
Not involving the specialist palliative care team — MDT approach is essential
Forgetting to discuss DNACPR/advance care planning — examiners expect senior-level thinking
Key Resources for Revision
** palliativedrugs.com** — Essential for drug compatibility and dosing
NICE Guideline NG31 — Care of dying adults in the last days of life
BNF — Palliative care section with conversion tables
Scottish Palliative Care Guidelines — Excellent, practical, and free online
'Oxford Handbook of Palliative Care' — Comprehensive reference for exam revision
Final Tips for Exam Day
Practise opioid conversion until it is automatic — you will be tested on this
Memorise the standard anticipatory prescribing chart — it appears in nearly every palliative care station
Demonstrate empathy — examiners are watching your human qualities as much as your knowledge
Always mention the MDT — specialist palliative care nurses, chaplaincy, social workers
Know when to escalate to inpatient palliative care — recognise when community management is insufficient
Palliative care in PACES rewards candidates who combine solid pharmacological knowledge with genuine compassion. Master both, and you will approach any palliative scenario with the confidence of a competent registrar.
Good luck with your PACES preparation. Remember: every patient encounter is an opportunity to demonstrate not just what you know, but who you are as a doctor.
Join the Discussion
Share your thoughts and insights with the medical community
Comments
Delete Comment
Are you sure you want to delete this comment? This action cannot be undone.